SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-056077
Filing Date
2024-05-09
Accepted
2024-05-08 19:13:29
Documents
66
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q acad-20240331.htm   iXBRL 10-Q 1590047
2 EX-10.1 acad-ex10_1.htm EX-10.1 66509
3 EX-10.2 acad-ex10_2.htm EX-10.2 92916
4 EX-10.3 acad-ex10_3.htm EX-10.3 174708
5 EX-31.1 acad-ex31_1.htm EX-31.1 10617
6 EX-31.2 acad-ex31_2.htm EX-31.2 10767
7 EX-32.1 acad-ex32_1.htm EX-32.1 7487
8 EX-32.2 acad-ex32_2.htm EX-32.2 7545
9 GRAPHIC img91857729_0.jpg GRAPHIC 278460
  Complete submission text file 0000950170-24-056077.txt   7646097

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acad-20240331.xsd EX-101.SCH 913316
69 EXTRACTED XBRL INSTANCE DOCUMENT acad-20240331_htm.xml XML 1237153
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 24928007
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)